SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-058233
Filing Date
2015-08-10
Accepted
2015-08-10 16:10:42
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12408_110q.htm 10-Q 855173
2 EX-10.2 a15-12408_1ex10d2.htm EX-10.2 65197
3 EX-10.3 a15-12408_1ex10d3.htm EX-10.3 76020
4 EX-31.1 a15-12408_1ex31d1.htm EX-31.1 11959
5 EX-31.2 a15-12408_1ex31d2.htm EX-31.2 11969
6 EX-32.1 a15-12408_1ex32d1.htm EX-32.1 7711
  Complete submission text file 0001104659-15-058233.txt   4174911

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cldx-20150630.xml EX-101.INS 946812
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20150630.xsd EX-101.SCH 29311
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20150630_cal.xml EX-101.CAL 50372
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20150630_lab.xml EX-101.LAB 299073
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20150630_pre.xml EX-101.PRE 192369
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20150630_def.xml EX-101.DEF 84025
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 151040860
SIC: 2835 In Vitro & In Vivo Diagnostic Substances